Swedish News Blog

Two Swedish Hospitals Join National Nursing Skills Program

Swedish News

Swedish First Hill and Cherry Hill hospitals have joined the American Association of Critical-Care Nurses (AACCN) Clinical Scene Investigator (CSI) Academy, a national quality improvement program designed to empower bedside nurses as clinician leaders.

“Involving nursing staff in a transformational leadership program such as the AACN CSI Academy truly helps inspire staff to take their nursing practice to the next level,” said June Altaras, Swedish’s chief nursing officer, in AACN’s news release announcing the program’s rollout in the Seattle region. “The evidence-based program supports nurses in their efforts to create relevant and lasting solutions for the health and safety of their patients.”

First Hill and Cherry Hill are two of the seven hospitals to offer this program in the Seattle region. Read the AACCN news release to learn more.

Swedish Honored for Achieving Quality Measures for Stroke Care

Swedish News

The American Heart/Stroke Associations recognize Swedish Cherry Hill with Stroke Gold-Plus Quality Achievement Award

SEATTLE, Nov. 3, 2014 – Swedish Health Services announced today its Cherry Hill campus received the Get With The Guidelines® Stroke Gold-Plus Quality Achievement Award from the American Heart Association/American Stroke Association.

The Get With The Guidelines Stroke program helps hospital teams provide the most up-to-date, research-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. The award indicates that Swedish Cherry Hill meets specific quality achievement measures for the diagnosis and treatment of stroke patients. These measures include aggressive use of medications and risk-reduction therapies aimed at reducing death and disability and improving the lives of stroke patients.
 
Swedish also received the association’s Target: Stroke Honor Roll for meeting stroke quality measures that reduce the time between hospital arrival and treatment with the clot-buster tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. People who suffer a stroke who receive the drug within three hours of the onset of symptoms may recover quicker and are less likely to suffer severe disability.

Swedish Specialty Dental Clinic for Low-Income Residents Receives National Recognition

Swedish News

Swedish Community Specialty Clinic’s oral surgery program receives Golden Apple award from the American Dental Association


SEATTLE—Oct. 16, 2014—The Swedish Community Specialty Clinic’s dental program, which has provided complex oral surgery care for more than 1,800 low-income adults, announced today that it received the American Dental Association’s Golden Apple Award for Excellence in Access to Dental Care Programs. The specialty dental program—a partnership between the Seattle - King County Dental Society, Project Access Northwest, Seattle Special Care Dentistry and Swedish — has provided more than $2.4 million in free care since its inception in 2011.
 
“Before this clinic opened, many low-income adults had nowhere to go but the emergency room when they had painful, acute dental conditions,” said Tom Gibbon, manager of the Swedish Community Specialty Clinic. “This program ensures that everyone, regardless of their ability to pay, has access to specialty dental care in the right place, at the right time.”
 
Patients with complex oral health conditions are referred to the Swedish Community Specialty Clinic’s dental program at the First Hill campus from safety-net dental clinics across King County.

Swedish Receives Consumer Choice Award from National Research Corporation

Swedish News

SEATTLE – October 13, 2014 – Swedish announced today it has received the 2014/2015 Consumer Choice Award from National Research Corporation. The annual award recognizes hospitals across the country for the highest quality and best reputation among area consumers.
 
Winners are determined by consumer perceptions on multiple quality and image ratings collected in the company’s Market Insights survey – the largest online consumer health care survey in the United States – surveying more than 290,000 households. Hospitals named by consumers are analyzed and ranked based on Core Based Statistical Areas defined by the U.S. Census Bureau, with winning facilities being ranked the highest.

Infectious disease protocols in place at Swedish

Swedish News


Swedish, like all U.S. hospitals, is prepared to follow Centers for Disease Control’s infectious disease recommendations and protocols. Due to recent infectious disease events, Swedish is increasing its use of screening measures to identify potential cases of infectious disease. These include:

  • Identifying a patient’s recent travel history
  • Diagnosing any physical symptoms a patient may be experiencing
If patients are identified to be at risk of having or spreading an infectious disease, Swedish caregivers are prepared to follow appropriate protocols, which may include patient isolation, distribution of appropriate protective equipment for caregivers and patients, restricting visitation and implementing environmental infection control measures. Disease testing only occurs after a screening threshold is met and the patient is identified as a risk.

Swedish Neuroscience Institute Performs Focused Ultrasound Procedure to Treat Metastatic Brain Tumor

Swedish News

Study is one of three trials at Swedish Medical Center in Seattle examining novel technology’s treatment potential


SEATTLE — Oct. 1, 2014 — Surgeons from the Swedish Neuroscience Institute (SNI) in Seattle have used focused ultrasound waves to noninvasively treat a metastatic brain tumor. The procedure was performed by Swedish neurosurgeon Stephen Monteith, M.D. and assisted by Charles Cobbs, M.D. and is part of an early stage clinical trial examining the novel technology.

The trial is one of three ongoing studies being conducted by SNI to evaluate the use of focused ultrasound – a technology traditionally associated with imaging and diagnostic procedures – for the noninvasive treatment of neurological disorders. The brain tumors trial, along with separate clinical trials examining focused ultrasound for the treatment of Parkinson’s disease and essential tremor, make SNI one of the nation’s leading research centers for the study of focused ultrasound.

Seattle Brain Cancer Walk Raises $530,000 for Brain Cancer Research

Swedish News

Funds will advance the search for new treatment options and improve patient care


SEATTLE — Sept. 26, 2014 — More than 3,000 walkers filled Seattle Center’s Next 50 Plaza on Sept. 20 for the 7th Annual Seattle Brain Cancer Walk. The walk raised more than $530,000, with 100 percent of the funds supporting research at the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute (Ivy Center).
 
“The Seattle Brain Cancer Walk is an opportunity to celebrate the patients and families who are all affected by this devastating disease,” said Charles Cobbs, M.D., medical director of the Ivy Center. “The funds raised will make a direct impact on our research at the Ivy Center, and will help us push toward breakthroughs to better treat, and hopefully cure this disease.”
 
According to the American Brain Tumor Association, brain tumors are the second leading cause of cancer-related deaths in Americans under the age of 20; the second leading cause of cancer-related deaths in men ages 20-39; and the fifth leading cause of cancer-related deaths in women ages 20-39.
 
Prior to the opening of the Ivy Center in 2008, clinical trials for patients with brain tumors were extremely limited in the Pacific Northwest. To date, the Ivy Center has provided access to 15 community-based clinical trials of experimental new therapies for patients diagnosed with brain cancer.

Results 8-14 of 100

More information about the Swedish newsroom

Explore the rest of the Swedish blog

Swedish has a social media policy

See who is blogging at Swedish

   Keep up with Swedish:

    Check out the Swedish blog

Find a Physician

              Subscribe to
             HealthWatch